Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 297-664-9 | CAS number: 93686-15-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Absorption, Distribution, Metabolism, Excretion:
The metabolic fate of 14C-AOS (a mixture of 14C-sodium alkenyl(2) sulfonate and 14C-sodium 3-hydroxy alkane sulfonate) has been studied in rats by a single oral and intravenous injection of 100 mg (50 μCi)/kg and 10 mg (5 μCi)/kg, respectively.
Oral absorption:
Absorption via the gastrointestinal tract after oral application was found to equal 80% of the radioactivity administered (Inoue et al., 1982).
After oral administration, 14C-AOS was rapidly absorbed from the gastrointestinal tract. The blood level of 14C-activity reached its peak 3 hours after dosing and then declined. Twenty-four hours after the dose, about 0.8%/g of the 14C-AOS given was detected in cecum content, but in other tissues the figures were under 0.02% dose/g. Within 24 hours after the dose, 72% of the dose was excreted in the urine and 22% in the feces, while the excretion in the bile was 4.3% within 12 hours. The administered radioactivity was rapidly eliminated from the whole body within 24 hours (Inoue et al., 1982).
Metabolites were accounting for most of the radioactivity found in liver, kidney, urine and bile. In blood the activity of intact Alpha Olefin Sulfonate was one third of that of the metabolites, in the gastrointestinal tract metabolites accounted for one third of the activity. The metabolites were more polar than intact Alpha Olefin Sulfonate and included hydroxylated, carboxylated and sulfonated forms.
Dermal absorption:
Percutaneous absorption of α-olefin sulfonate (AOS) through intact skin was found to be very low (below 1% based on experimental data).
After application of 14C-AOS to the intact skin 60 - 70% of total radioactivity was recovered by skin washes, 0.62% of the applied dose was absorbed, and 0.298% of the applied dose was detected in urine (Minegishi et al., 1977).
Radioactivity could be detected in bile and urine within 1 hour after application to intact skin, but in very low amounts. Among the organs liver and kidney showed the highest amounts of radioactivity (0.123% and 0.059% of applied dose, respectively) 24 hours after application. Total recovery from urine, bile and main organs was about 0.62% of the applied dose after 24 hours (Minegishi et al., 1977).
Distribution
After oral and dermal application most of the radioactivity was found in liver (bile) and kidneys (urine).
Metabolism /Excretion
Metabolites were accounting for most of the radioactivity found in liver, kidney, urine and bile. In blood the activity of intact Alpha Olefin Sulfonate was one third of that of the metabolites, in the gastrointestinal tract metabolites accounted for one third of the activity. The metabolites were more polar than intact Alpha Olefin Sulfonate and included hydroxylated, carboxylated and sulfonated forms.
No intact 14C-AOS was detected in any of the urine samples after oral and intravenous doses. The metabolite was apparently more polar than intact 14C-AOS, and results from data of electrophoresis and equilibrium dialysis indicated that in fact 14C-AOS can bind with proteins, while the metabolites cannot. The metabolite was found to contain alcoholic, unsaturated and sulfonic acid functionalities. It is suggested that the metabolite may be a hydroxylated or polyhydroxylated sulfonic acid of shorter chain length than AOS. These results suggest that 14C-AOS is rapidly absorbed, metabolized and excreted, therefore, no accumulation of 14C-AOS is expected (Minegishi et al., 1977).
Inoue, S. et al. 1982: Metabolism of alpha-olefin sulfonate (AOS) in rats. Fundamental and applied toxicology 2(3): 130-138
Minegishi, K. et al. 1977: Percutaneous absorption of α-olefin sulfonate (AOS) in rats. Chem Pharm Bull 25(4): 821-825
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 80
- Absorption rate - dermal (%):
- 1
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.